Pharma Journalist - Page 86 of 946 -

Aurisco Passes FDA Inspection for Generic Oligonucleotide APIs

Alfasigma to Acquire Nordic Pharma in Global Expansion

Lilly Files Six Lawsuits Against Black-Market Retatrutide Sellers

Health Canada Approves Novartis’ KISQALI for High-Risk Early Breast Cancer

Advarra Launches AI Council to Boost Innovation in Clinical Trials

RyboDyn Joins Lilly Gateway Labs to Advance Immunotherapies Targeting Dark Proteome

Yeztugo Becomes First FDA-Approved HIV Prevention with 6-Month Protection

Actio Biosciences Raises $66M in Series B to Advance Genetics-Based Therapies

FNP-223 Receives FDA Fast Track Designation for Progressive Supranuclear Palsy

J&J Seeks FDA Approval of STELARA for Pediatric Crohn’s Disease

Draig Therapeutics Launches with $140M to Tackle Neuropsychiatric Disorders

Dyne’s DYNE-101 Earns FDA Breakthrough Status, Eyes Accelerated DM1 Approval

BioAegis Gets FDA Fast Track for ARDS Treatment with Gelsolin